Showing the latest 10 filings. Sign in to filter or browse the full history.
Showing 10 of 30 filings.
13 Oct 20261 filing
AGM details
- AGM held on 30 September 2026 at 11:00 A.M.
- Mode: remote e-voting and e-voting at the Meeting
- No record/book closure dates mentioned
Resolutions passed
- Resolution 1 (Ordinary): Adoption of Audited Financial Statements for year ended 31 Mar 2026; passed
- Resolution 2 (Ordinary): Reappointment of Anupam Narain Gupta by rotation; passed
Director changes
- Anupam Narain Gupta reappointed by rotation
Voting results (summary)
- Resolution 1 passed with majority per Scrutinizer's report
- Resolution 2 passed by ordinary majority
30 Sept 20261 filing
AGM proceedings
- AGM held 30 September 2026 at 11:00 A.M. at the registered office (physical).
- Quorum was established and meeting proceeded with overview of performance and outlook.
- Item 1: Ordinary resolution to adopt Standalone Audited Financial Statements for year ended 31 March 2026.
- Item 2: Ordinary resolution to re-appoint director by rotation: Anupam Narain Gupta.
- Scrutinizer appointed: CS Chirag Jain, Practicing Company Secretary, to scrutinize e-voting.
- E-voting results to be declared after Scrutinizers report; to be hosted on company and CDS websites.
- Results to be sent to stock exchange within two working days from AGM.
- Chairman concluded meeting with vote of thanks at 11:30 A.M.
28 Sept 20261 filing
Meeting Details
- Board meeting scheduled for Thursday, October 01, 2026; time and venue not disclosed.
Key Agenda Items
- Increase the company's authorised share capital.
- Raise funds via preferential issue of equity shares and/or convertible warrants to promoters/non-promoters, subject to approvals.
- To transact other incidental and ancillary matters as decided by the Board with chairperson's permission.
Other Notes
- No additional material notes disclosed.
26 Sept 20261 filing
Transaction details
- Target company: Pro Fin Capital Services Ltd.
- Acquirer and PAC: Acquirer—DILKHUSH BAFNAJ; PAC: None.
- Promoter group: No.
- Stock exchange: BSE Ltd.
- Pre-acquisition holding: 29,666,754 shares (5.00%), encumbrances/VR/warrants: NA.
- Acquisition details: 29,666,754 voting shares acquired via open market; 5.00%.
- Post-acquisition holding: 29,666,754 shares (5.00%).
- Mode of acquisition: Open Market.
- Date of acquisition: 25-09-2026.
- Equity share capital before: Rs 592,594,326 (592,594,326 shares).
- Equity share capital after: Rs 592,594,326 (same as before).
- Total diluted share/voting capital after: Rs 592,594,326.
- Salient features: NA.
7 Sept 20261 filing
AGM & notices
- 35th AGM on 30 Sep 2026 at 11:00 AM, Borivali East, Mumbai.
- Remote e-voting: 27-29 Sep 2026; cut-off 23 Sep 2026.
- Annual Report & Notice available on company website.
- Notice is being sent electronically to registered members.
Financial performance
- Income for year: 7169.20 lakh; prior year 3169.12 lakh.
- Profit after tax: -260.08 lakh; prior year 291.99 lakh.
- No dividend declared for 2025-26.
- Paid-up capital: Rs 2962.97 lakh.
Capital structure & liquidity
- Borrowings (excluding debt securities): 28,054.87 lakh.
- Cash and cash equivalents: 21.48 lakh.
- Total assets: 38976.50 lakh; total equity: 6785.88 lakh.
Governance & audit
- Board of 6 directors; 3 executive, 3 independent.
- Audit Committee met 4 times; Chair Kinjal Vora.
- Secretarial audit flagged non-filing of annual returns & compliance calendar; scope limitations.
- Past SEBI LODR penalties noted (2022-23, 2022).
- Current year: no audit qualification; management to address gaps.
Related party transactions
- Loans to related parties outstanding: Loshika Bioscience 831.42 lakh; Triyamb Securities 21.65 lakh; Profin Commodities 105.67 lakh.
- All related party transactions at arm's length; disclosed in notes.
Market & listing
- Listed on BSE; scrip code 511557.
- Market data: Dec 2025 high 15.28; low 2.25.
- No GDRs/ADRs issued.
Shareholding & promoters
- Promoter & promoter group 3.91%; Public 96.09%.
- Largest holders: Ramesh Sawalram Saraogi 15.86%; Triyamb Securities 3.77%.
Outlook & risks
- NBFC sector remains growth-positive; performance linked to economy & capital markets.
- Key risks: operational, credit, regulatory, macroeconomic volatility.
Auditors & internal controls
- Statutory auditors: M/s KS Subrahmanyam & Co; unqualified opinion.
- Internal financial controls judged adequate and operating effectively.
3 Sept 20261 filing
Key outcomes
- The 35th AGM will be held on September 30, 2026.
- Book closure will be from September 24, 2026 to September 30, 2026 (inclusive).
- Directors’ Reports with annexures for FY 2024-25 approved.
31 Aug 20261 filing
Meeting Details
- Board meeting scheduled for Sep 3, 2026; time and venue not disclosed.
Key Agenda Items
- To fix AGM date, time, venue, and mode; approve Directors' Report with annexures.
- To approve book closure for the 35th AGM.
- To transact incidental matters with Chairperson's permission.
Other Notes
- No additional material notes disclosed.
18 Aug 20261 filing
Board actions
- Approved unaudited standalone results for the quarter ended June 30, 2026.
- Took note of the Limited Review Report by statutory auditors.
- Unaudited results available on the company's website.
12 Aug 20261 filing
Board meeting adjournment
- Board meeting for Q1 unaudited results postponed from 12 Aug 2026 to 13 Aug 2026.
- Consent of Chairman and directors obtained to adjourn the meeting.
- No other items finalized; adjournment to consider any items with Chairman's permission.
6 Aug 20261 filing
Meeting Details
- Board meeting scheduled for August 12, 2026; time and venue not disclosed.
Key Agenda Items
- Unaudited quarterly financial results for the quarter ended June 30, 2026.
- Limited review report on unaudited quarterly results for the quarter ended June 30, 2026.
- To transact incidental and ancillary matters with the Chairperson's permission.
Other Notes
- Trading window closed from July 1, 2026 until 48 hours after results declaration.